ASCO 2024 abstracts released—Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial —Bicycle Therapeutics scores $555M investment for disease prevention --http://bit.ly/w28kSd #asco2024 #asco #ozempic #kidneydisease #novonordisk #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma